ChrysCapital invests in Indian formulations firm Eris Lifesciences
This article was originally published in Scrip
Executive Summary
ChrysCapital, an India-focused investment firm, has entered into a private equity transaction - its first in the pharmaceutical space this year - with the branded formulations company, Eris Lifesciences.